Guanhao Biotech Co.,Ltd. (300238.SZ)
CNY 13.98
(-1.48%)
CNY 13.98
(-1.48%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 399.81 Million | 377.28 Million | 488.98 Million | 436.95 Million | 437.88 Million | 458.46 Million |
| Cost of Revenue | 101.61 Million | 89.62 Million | 121.68 Million | 120.04 Million | 141.44 Million | 125.96 Million |
| Gross Profit | 298.19 Million | 287.66 Million | 367.29 Million | 316.91 Million | 296.44 Million | 332.49 Million |
| Operating Expenses | 285.82 Million | 238.43 Million | 264.45 Million | 248.62 Million | 337.69 Million | 268.37 Million |
| Selling, General and Administrative Expenses | 228.62 Million | 177.57 Million | 200.98 Million | 196.62 Million | 249.23 Million | 204.99 Million |
| Research and Development Expenses | 44.5 Million | 50.51 Million | 46.62 Million | 34.25 Million | 69.95 Million | 42.95 Million |
| Other Expenses | 8.8 Million | -541.63 Thousand | 498.79 Thousand | -88.04 Thousand | 1.97 Million | 8.62 Million |
| Cost and Expenses | 370.19 Million | 328.05 Million | 386.14 Million | 368.66 Million | 479.13 Million | 394.33 Million |
| Operating Income | 33.98 Million | -292.04 Million | 81.55 Million | 44.96 Million | -486.85 Million | 43.44 Million |
| Interest Expense | 1.78 Million | 4.11 Million | 7.36 Million | 14.58 Million | 15.77 Million | 22.79 Million |
| Income Tax Expense | 11.01 Million | 35.07 Million | 31.31 Million | 3.51 Million | 5.87 Million | 16.95 Million |
| Earnings before Tax | 32.08 Million | -292.58 Million | 82.05 Million | 44.87 Million | -484.87 Million | 52.06 Million |
| Net Income | 31 Million | -307.83 Million | 73.68 Million | 46.59 Million | -465.32 Million | 45.74 Million |
| Earnings Per Share Basic | 0.12 | -1.16 | 0.28 | 0.18 | -1.75 | 0.17 |
| Earnings Per Share Diluted | 0.12 | -1.16 | 0.28 | 0.18 | -1.75 | 0.17 |
| Weighted Average Shares Outstanding | 258.38 Million | 265.15 Million | 265.15 Million | 265.15 Million | 265.15 Million | 265.15 Million |
| Weighted Average Shares Outstanding (Diluted) | 258.38 Million | 265.15 Million | 265.15 Million | 265.15 Million | 265.15 Million | 269.09 Million |
| Gross Margin | 0.75 | 0.76 | 0.75 | 0.73 | 0.68 | 0.73 |
| EBIT Margin | 0.16 | 0.18 | 0.28 | 0.22 | -0.05 | 0.24 |
| Profit Margin | 0.08 | -0.82 | 0.15 | 0.11 | -1.06 | 0.10 |
| EBITDA | 62.87 Million | -234.75 Million | 146.15 Million | 97.72 Million | -418.59 Million | 116.51 Million |
| Earnings Before Tax Margin | 0.09 | -0.77 | 0.17 | 0.10 | -1.11 | 0.09 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 88.43 Million | 97.16 Million | 90.58 Million | 399.81 Million | 93.98 Million | 98.13 Million |
| Cost of Revenue | 17.33 Million | 25.74 Million | 20.07 Million | 101.61 Million | 27.47 Million | 13.26 Million |
| Gross Profit | 71.09 Million | 71.42 Million | 70.51 Million | 298.19 Million | 66.51 Million | 84.87 Million |
| Operating Expenses | 64.52 Million | 66.16 Million | 50.95 Million | 262.32 Million | 76.01 Million | 65.32 Million |
| Selling, General and Administrative Expenses | 94.98 Million | 58.92 Million | 43.73 Million | - | 61.67 Million | 69.68 Million |
| Research and Development Expenses | 12.06 Million | 7.09 Million | 7.48 Million | - | 13.72 Million | 10.33 Million |
| Other Expenses | -42.52 Million | -150.83 Thousand | 264.38 Thousand | -3.89 Million | -617.04 Thousand | -414.95 Thousand |
| Cost and Expenses | 81.86 Million | 91.91 Million | 71.02 Million | 363.94 Million | 103.48 Million | 78.58 Million |
| Operating Income | 5.44 Million | 5.25 Million | 19.56 Million | 35.86 Million | -9.49 Million | 10.5 Million |
| Interest Expense | 146.85 Thousand | 153.29 Thousand | 159.79 Thousand | 3.36 Million | 391.28 Thousand | 371.97 Thousand |
| Income Tax Expense | 1.55 Million | 4.11 Million | 5 Million | 11.01 Million | 5.16 Million | 2.16 Million |
| Earnings before Tax | 5.45 Million | 5.64 Million | 20.6 Million | 32.56 Million | -11.79 Million | 10.08 Million |
| Net Income | 7.68 Million | 5.75 Million | 14.39 Million | 31 Million | -10.26 Million | 10.52 Million |
| Earnings Per Share Basic | 0.03 | 0.02 | 0.05 | - | -0.04 | 0.04 |
| Earnings Per Share Diluted | 0.03 | 0.02 | 0.05 | - | -0.04 | 0.04 |
| Weighted Average Shares Outstanding | 265.15 Million | 265.15 Million | 265.15 Million | 265.15 Million | 265.15 Million | 265.15 Million |
| Weighted Average Shares Outstanding (Diluted) | 265.15 Million | 265.15 Million | 265.15 Million | 265.15 Million | 265.15 Million | 265.15 Million |
| Gross Margin | 0.80 | 0.74 | 0.78 | 0.75 | 0.71 | 0.86 |
| EBIT Margin | 0.06 | 0.12 | 0.23 | - | -0.00 | 0.18 |
| Profit Margin | 0.09 | 0.06 | 0.16 | 0.08 | -0.11 | 0.11 |
| EBITDA | 5.6 Million | 11.43 Million | 20.89 Million | - | -410.33 Thousand | 17.79 Million |
| Earnings Before Tax Margin | 0.06 | 0.05 | 0.22 | 0.09 | -0.10 | 0.11 |
VIPRF
BBT
MYN
600724
ONEGLOBAL
FAR